A personalized mRNA Vaccine provides ‘real hope’ for melanoma patients | The Optimist Daily
www.optimistdaily.com
Redefining cancer therapy: a closer look at the cutting-edge mRNA vaccine trials for melanoma.

I missed this before, but apparently we're now nearly a year into Merck and Moderna's Phase-3 trials of a novel mRNA vaccine (mRNA-4157) in combination with Keytruda to slow or halt aggressive melanoma growth. (press release), and about 4 months into a similar Phase 3 trial of the same drug combo for small cell lung cancer (press release). Here's hoping that 2025 is the year we cure (some kinds of) cancer!

  • zephorah@lemm.ee
    ·
    4 days ago

    There are people in hospital, on the cusp of death, who will refuse to receive blood because it’s unknown whether it’s “vaccinated” mRNA blood or not.

    I’m curious to see how this goes.